Resalis Therapeutics

Moonwalk Biosciences

The company develops adipose-targeted RNA therapies to treat obesity and cardiometabolic diseases for patients requiring weight loss and lean mass preservation.

Akero Therapeutics

This company develops metabolic disease treatments for patients with metabolic dysfunction-associated steatohepatitis and other liver conditions.

Moonwalk Therapeutics

This biotechnology company develops epigenetic and RNA interference medicines to treat obesity and cardiometabolic diseases for patients.

Northsea Therapeutics

This company develops structurally engineered fatty acid drugs for patients with metabolic, inflammatory, and fibrotic diseases such as rare liver disorders.

Tanai Therapeutics

This company develops oral small molecule therapeutics targeting energy expenditure pathways to treat obesity and cardiometabolic diseases for patients.

Alveus Therapeutics

This clinical-stage biotechnology company develops next-generation therapies for obesity and metabolic diseases to provide sustained weight loss for patients.

Metabolys

This biopharmaceutical company develops oral small molecules to treat metabolic diseases, specifically non-alcoholic steatohepatitis and type 2 diabetes, for the global healthcare market.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.